Home > Riviste > The Journal of Sports Medicine and Physical Fitness > Fascicoli precedenti > Articles online first > The Journal of Sports Medicine and Physical Fitness 2021 Jul 13

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

The Journal of Sports Medicine and Physical Fitness 2021 Jul 13

DOI: 10.23736/S0022-4707.21.12764-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?

Domenico FILOMENA 1, 2, Lucia I. BIRTOLO 1, 2, Marco PENZA 2, 3, Gianfranco GUALDI 2, Barbara DI GIACINTO 2, Viviana MAESTRINI 1, 2

1 Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy; 2 Institute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Rome, Italy; 3 Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy


PDF


Recent reports based on Cardiovascular Magnetic Resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening protocol after COVID-19 has been questioned. Current evidence does not seem to support the routine use of CMR and the prescription of CMR should be based upon clinical indication.


KEY WORDS: COVID-19; Athletes; CMR

inizio pagina